The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review
- PMID: 22536064
- PMCID: PMC3333818
- DOI: 10.2147/PPA.S30244
The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review
Abstract
Objective: Due to the rapid proliferation of human immunodeficiency virus (HIV) treatment options, there is a need for health care providers with knowledge of antiretroviral therapy intricacies. In a HIV multidisciplinary care team, the HIV pharmacist is well-equipped to provide this expertise. We conducted a systematic review to assess the impact of HIV pharmacists on HIV clinical outcomes.
Methods: We searched six electronic databases from January 1, 1980 to June 1, 2011 and included all quantitative studies that examined pharmacist's roles in the clinical care of HIV-positive adults. Primary outcomes were antiretroviral adherence, viral load, and CD(4) (+) cell count and secondary outcomes included health care utilization parameters, antiretroviral modifications, and other descriptive variables.
Results: Thirty-two publications were included. Despite methodological limitation, the involvement of HIV pharmacists was associated with statistically significant adherence improvements and positive impact on viral suppression in the majority of studies.
Conclusion: This systematic review provides evidence of the beneficial impact of HIV pharmacists on HIV treatment outcomes and offers suggestions for future research.
Keywords: HIV/AIDS; adherence; clinical; impact; pharmacist.
Figures
Similar articles
-
Effect of pharmacist care on clinical outcomes among people living with HIV/AIDS: A systematic review and meta-analysis.Res Social Adm Pharm. 2022 Jun;18(6):2962-2980. doi: 10.1016/j.sapharm.2021.07.020. Epub 2021 Jul 28. Res Social Adm Pharm. 2022. PMID: 34353754 Review.
-
Improving adherence and clinical outcomes through an HIV pharmacist's interventions.AIDS Care. 2010 Oct;22(10):1189-94. doi: 10.1080/09540121003668102. AIDS Care. 2010. PMID: 20640958
-
The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.Prim Care Diabetes. 2020 Oct;14(5):393-400. doi: 10.1016/j.pcd.2019.12.007. Epub 2020 Jan 8. Prim Care Diabetes. 2020. PMID: 31926868
-
Reporting of critical information in studies of pharmacists in HIV care.Int J Pharm Pract. 2014 Dec;22(6):375-85. doi: 10.1111/ijpp.12096. Epub 2014 Jan 27. Int J Pharm Pract. 2014. PMID: 24467531 Free PMC article. Review.
-
Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.Res Social Adm Pharm. 2018 Jun;14(6):507-520. doi: 10.1016/j.sapharm.2017.06.004. Epub 2017 Jun 13. Res Social Adm Pharm. 2018. PMID: 28641999 Review.
Cited by
-
Pharmacist-Driven Rapid Initiation of Antiretroviral Therapy Decreases Time to Viral Suppression in People With HIV.Open Forum Infect Dis. 2024 Apr 26;11(5):ofae237. doi: 10.1093/ofid/ofae237. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38737433 Free PMC article.
-
Levels of agreement among clinical pharmacists on the impact of pharmaceutical interventions in Oman: A retrospective analysis.Pharm Pract (Granada). 2022 Jul-Sep;20(3):2708. doi: 10.18549/PharmPract.2022.3.2708. Epub 2022 Sep 14. Pharm Pract (Granada). 2022. PMID: 36733521 Free PMC article.
-
Pharmacist-delivered HIV point-of-care testing in Ontario: Lessons learned from the GetaTest pilot.Can Pharm J (Ott). 2022 Oct 2;155(6):309-314. doi: 10.1177/17151635221128001. eCollection 2022 Nov. Can Pharm J (Ott). 2022. PMID: 36386610 Free PMC article. No abstract available.
-
The Impacts of Clinical Pharmacists' Interventions on Clinical Significance and Cost Avoidance in a Tertiary Care University Hospital in Oman: A Retrospective Analysis.Pharmacy (Basel). 2022 Oct 3;10(5):127. doi: 10.3390/pharmacy10050127. Pharmacy (Basel). 2022. PMID: 36287448 Free PMC article.
-
Clinically significant drug interactions between antiretroviral and co-prescribed drugs in HIV infected patients: retrospective cohort study.Med Pharm Rep. 2022 Jul;95(3):260-266. doi: 10.15386/mpr-2305. Epub 2022 Jul 26. Med Pharm Rep. 2022. PMID: 36060510 Free PMC article.
References
-
- Centers for Disease Control (CDC) Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30(21):250–252. - PubMed
-
- Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. DICP. 1991;25(12):1374–1378. - PubMed
-
- Crawford NS. Organizing pharmacists to help fight AIDS. Am Pharm. 1991;NS31(3):44–47. - PubMed
-
- McKnight PT, Visconti JA, Gower RE, Para MF. Zidovudine: counseling strategies and Compliance. Am Pharm. 1991;31(10):38–43. - PubMed
-
- Weingarten CM, Freeland B. Pharmacist participation on an HIV resource team. Am J Health Syst Pharm. 1995;52(12):1282–1284. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials